HK1219293A1 - 產生軟骨細胞譜系細胞和/或類軟骨組織的方法和組合物 - Google Patents
產生軟骨細胞譜系細胞和/或類軟骨組織的方法和組合物Info
- Publication number
- HK1219293A1 HK1219293A1 HK16107222.7A HK16107222A HK1219293A1 HK 1219293 A1 HK1219293 A1 HK 1219293A1 HK 16107222 A HK16107222 A HK 16107222A HK 1219293 A1 HK1219293 A1 HK 1219293A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cartilage
- tissue
- compositions
- methods
- lineage cells
- Prior art date
Links
- 210000000845 cartilage Anatomy 0.000 title 1
- 210000004027 cell Anatomy 0.000 title 1
- 210000001612 chondrocyte Anatomy 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 210000001519 tissue Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0655—Chondrocytes; Cartilage
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/02—Drug screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361809050P | 2013-04-05 | 2013-04-05 | |
PCT/CA2014/000312 WO2014161075A1 (en) | 2013-04-05 | 2014-04-02 | Methods and compositions for generating chondrocyte lineage cells and/or cartilage like tissue |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1219293A1 true HK1219293A1 (zh) | 2017-03-31 |
Family
ID=51657353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16107222.7A HK1219293A1 (zh) | 2013-04-05 | 2016-06-22 | 產生軟骨細胞譜系細胞和/或類軟骨組織的方法和組合物 |
Country Status (11)
Country | Link |
---|---|
US (3) | US9993504B2 (zh) |
EP (2) | EP3896153A1 (zh) |
JP (4) | JP6516724B2 (zh) |
KR (4) | KR102393715B1 (zh) |
CN (2) | CN105209607B (zh) |
AU (3) | AU2014247679A1 (zh) |
CA (1) | CA2908369C (zh) |
HK (1) | HK1219293A1 (zh) |
SG (1) | SG10201708195RA (zh) |
WO (1) | WO2014161075A1 (zh) |
ZA (2) | ZA201507731B (zh) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201509264D0 (en) * | 2015-05-29 | 2015-07-15 | Univ Leuven Kath | Novel ATMP's |
WO2017026878A1 (ko) * | 2015-08-13 | 2017-02-16 | 전북대학교 산학협력단 | 근골격계 전구세포 유도용 배지 조성물 및 근골격계 전구세포를 포함하는 근골격계 질환 예방 또는 치료용 약학적 조성물 |
JP7000311B2 (ja) * | 2016-03-23 | 2022-02-04 | 国立大学法人京都大学 | 血球分化能の高い中胚葉誘導方法 |
US20200299643A1 (en) * | 2016-03-31 | 2020-09-24 | Keio University | Differentiation-promoted pluripotent stem cell and use thereof |
CN109689860A (zh) | 2016-09-12 | 2019-04-26 | 哈佛学院院长及董事 | 转录因子控制干细胞的分化 |
WO2018062269A1 (ja) * | 2016-09-30 | 2018-04-05 | 京都府公立大学法人 | 体細胞を製造する方法、体細胞、及び組成物 |
CN109996866A (zh) | 2016-12-02 | 2019-07-09 | 宝生物工程株式会社 | 用于产生内皮细胞的方法 |
GB201621594D0 (en) * | 2016-12-19 | 2017-02-01 | Univ Leuven Kath | Novel cell based methods for healing of bone, cartilage and joint disorders |
US10767164B2 (en) | 2017-03-30 | 2020-09-08 | The Research Foundation For The State University Of New York | Microenvironments for self-assembly of islet organoids from stem cells differentiation |
CN107365741B (zh) * | 2017-06-02 | 2019-08-30 | 新乡医学院 | NCAM缺失在促进BMSCs向肥大软骨细胞分化中的应用 |
CN107354126B (zh) * | 2017-06-02 | 2019-08-30 | 新乡医学院 | Ncam沉默在促进atdc5细胞的软骨细胞肥大分化中的应用 |
EP3417888A1 (de) * | 2017-06-25 | 2018-12-26 | co.don AG | Verfahren zum herstellen von transplantierbarem knorpelgewebe |
US20200121726A1 (en) | 2017-06-30 | 2020-04-23 | Kolon Life Science, Inc. | Pharmaceutical composition for preventing or treating osteoarthritis |
US11696929B2 (en) | 2017-09-20 | 2023-07-11 | The Regents Of The University Of California | Methods and systems for conserving highly expanded cells |
DK3702445T3 (da) | 2017-10-25 | 2023-01-09 | Cellatoz Therapeutics Inc | Hidtil ukendt muskuloskeletal stamcelle |
WO2019094389A1 (en) * | 2017-11-08 | 2019-05-16 | The Regents Of The University Of Colorado, A Body Corporate | Biodegradable biomimetics of growth plate cartilage for the treatment of physeal injuries |
WO2019195675A1 (en) | 2018-04-06 | 2019-10-10 | President And Fellows Of Harvard College | Methods of identifying combinations of transcription factors |
KR102121602B1 (ko) * | 2018-06-27 | 2020-06-10 | 주식회사 티아라줄기세포연구소 | 지방줄기세포배양용 배지 조성물 제조방법, 지방줄기세포배양용 배지 조성물 제조방법과 줄기세포 유효성분 3저 추출법을 이용한 줄기세포파쇄추출물(쉘드줄기세포) 제조방법, 이를 이용한 항관절염 치료용 조성물, 이를 이용한 염증억제 효과를 갖는 조성물 및 세포재생 효과를 갖는 조성물 |
CN110016461A (zh) * | 2019-01-15 | 2019-07-16 | 深圳市第二人民医院 | 一种软骨细胞体外扩增方法 |
WO2020205720A2 (en) * | 2019-03-29 | 2020-10-08 | Kolon Tissuegene, Inc. | Mixed-cell gene therapy |
WO2020237141A1 (en) * | 2019-05-22 | 2020-11-26 | The Cleveland Clinic Foundation | Generating dorsal foregut, and anterior domain, endoderm cells |
WO2021037142A1 (en) * | 2019-08-27 | 2021-03-04 | The Third Hospital Of Hebei Medical University | Multipotent joint progenitor cells, compositions and methods thereof |
WO2021054449A1 (ja) * | 2019-09-18 | 2021-03-25 | 国立大学法人 岡山大学 | Lbm、cpc、opc、それらの調製方法及び品質管理方法、キット、移植材料並びに疾患モデル |
EP3872168A1 (en) * | 2020-02-28 | 2021-09-01 | Cline Scientific AB | Chondrocyte differentiation |
KR20230004559A (ko) * | 2020-04-27 | 2023-01-06 | 토카이 유니버시티 에듀케이셔널시스템 | 연골 유래 Tie2 양성 세포를 포함하는 세포 집단의 배양 방법 및 그 이용 |
CN111840514B (zh) * | 2020-08-14 | 2021-07-30 | 武汉大学 | Cilp2在制备改善心脏衰老和心肌肥厚的药物中的应用 |
WO2022040560A1 (en) | 2020-08-21 | 2022-02-24 | Genzyme Corporation | Fgfr3 antibodies and methods of use |
CN117716021A (zh) * | 2021-08-31 | 2024-03-15 | 公立大学法人横滨市立大学 | 可成型且无需支架的软骨组织的制作方法 |
CA3233545A1 (en) * | 2021-10-14 | 2023-04-20 | Murdoch Children's Research Institute | Methods for producing cartilage and bones |
WO2023159062A2 (en) * | 2022-02-15 | 2023-08-24 | University Of Central Florida Research Foundation, Inc. | Anabolic drugs stimulating type ii collagen production from chondrocytes or their progenitors |
WO2023178239A1 (en) * | 2022-03-16 | 2023-09-21 | The Children's Medical Center Corporation | Hpsc-derived articular chondrocyte compositions, systems and methods of use thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
US5994619A (en) | 1996-04-01 | 1999-11-30 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Production of chimeric bovine or porcine animals using cultured inner cell mass cells |
US5945577A (en) | 1997-01-10 | 1999-08-31 | University Of Massachusetts As Represented By Its Amherst Campus | Cloning using donor nuclei from proliferating somatic cells |
US9074190B2 (en) * | 2003-10-07 | 2015-07-07 | Biomaster, Inc. | Cell differentiation of adipose-derived precursor cells |
JPWO2010008100A1 (ja) * | 2008-07-17 | 2012-01-05 | 国立大学法人名古屋大学 | 骨格筋細胞又は骨細胞の誘導法 |
US20120100117A1 (en) * | 2009-04-24 | 2012-04-26 | Daniele Noel | Method for chondrogenic differentiation of pluripotent or multipotent stem cells using wnt6 |
CN102844036B (zh) * | 2009-07-16 | 2016-01-20 | 生物时代股份有限公司 | 用于体外和体内软骨发生的方法和组合物 |
JP6263329B2 (ja) * | 2009-11-24 | 2018-01-17 | ザ ユニバーシティ オブ コネチカット | ヒト胚性および人工多能性幹細胞の分化 |
WO2012013969A1 (en) * | 2010-07-26 | 2012-02-02 | The University Of Manchester | Targeted differentiation of stem cells |
US20130052729A1 (en) * | 2011-08-29 | 2013-02-28 | Olivier Pourquie | Method for preparing induced paraxial mesoderm progenitor (ipam) cells and their use |
WO2013030243A1 (en) * | 2011-08-29 | 2013-03-07 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Method for preparing induced paraxial mesoderm progenitor (ipam) cells and their use |
-
2014
- 2014-04-02 WO PCT/CA2014/000312 patent/WO2014161075A1/en active Application Filing
- 2014-04-02 US US14/782,070 patent/US9993504B2/en active Active
- 2014-04-02 KR KR1020157031441A patent/KR102393715B1/ko active IP Right Grant
- 2014-04-02 CN CN201480028250.4A patent/CN105209607B/zh active Active
- 2014-04-02 CN CN202010058061.9A patent/CN111269880A/zh active Pending
- 2014-04-02 SG SG10201708195RA patent/SG10201708195RA/en unknown
- 2014-04-02 JP JP2016505658A patent/JP6516724B2/ja active Active
- 2014-04-02 KR KR1020237036016A patent/KR20230152164A/ko not_active Application Discontinuation
- 2014-04-02 CA CA2908369A patent/CA2908369C/en active Active
- 2014-04-02 EP EP20193958.4A patent/EP3896153A1/en active Pending
- 2014-04-02 EP EP14778943.2A patent/EP2981606B1/en active Active
- 2014-04-02 AU AU2014247679A patent/AU2014247679A1/en not_active Abandoned
- 2014-04-02 KR KR1020227014263A patent/KR20220057660A/ko not_active Application Discontinuation
- 2014-04-02 KR KR1020217036841A patent/KR102393716B1/ko active IP Right Grant
-
2015
- 2015-10-15 ZA ZA2015/07731A patent/ZA201507731B/en unknown
-
2016
- 2016-06-22 HK HK16107222.7A patent/HK1219293A1/zh unknown
-
2018
- 2018-05-11 US US15/977,536 patent/US10736923B2/en active Active
- 2018-12-10 ZA ZA2018/08312A patent/ZA201808312B/en unknown
-
2019
- 2019-04-16 JP JP2019077464A patent/JP2019141074A/ja active Pending
-
2020
- 2020-06-18 AU AU2020204058A patent/AU2020204058A1/en not_active Abandoned
-
2021
- 2021-03-15 JP JP2021040964A patent/JP2021104021A/ja active Pending
-
2022
- 2022-10-14 AU AU2022252839A patent/AU2022252839A1/en active Pending
-
2023
- 2023-01-26 JP JP2023010084A patent/JP2023061961A/ja active Pending
- 2023-06-16 US US18/336,410 patent/US20230330152A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1219293A1 (zh) | 產生軟骨細胞譜系細胞和/或類軟骨組織的方法和組合物 | |
IL251576A0 (en) | Methods and compositions for creating or maintaining multifunctional cells | |
GB201521857D0 (en) | SC-# cells and compositions and methods for generating the same | |
IL267283A (en) | Methods and preparations for producing epicardial cells | |
EP2904094A4 (en) | MICRONIZED COMPOSITIONS COMPRISING BONE GRAFTS AND METHODS OF MAKING AND USING SAME | |
HK1221171A1 (zh) | 用於刺激骨生長的組合物 | |
IL265876A (en) | Preparations that include 15-ohepa and methods of using them | |
EP2978463A4 (en) | BONE TRANSPLANT COMPOSITION AND MANUFACTURING METHOD THEREFOR | |
HUE062176T2 (hu) | Mûtrágya készítmények, eljárás ezek elõállítására és alkalmazásuk | |
EP2970915A4 (en) | METHOD AND COMPOSITIONS FOR PRODUCING STABILIZED TRANSFECTED CELLS | |
PT3148517T (pt) | Composições e métodos para promover a formação óssea | |
EP3041485A4 (en) | Cell-seeded compositions and methods useful for treating bone regions | |
IL240766A0 (en) | Artificial bone molds and works for bone approximation | |
HK1223852A1 (zh) | 睪丸酮凝膠組合物及相關方法 | |
EP2964330A4 (en) | COMPOSITIONS AND METHODS FOR CARDIAC TISSUE REPAIR | |
EP3003487A4 (en) | Trans-clomiphene and its analogues as agents that increase bone mineral density | |
GB201300628D0 (en) | Compositions comprising 15-OHEPA and methods of using the same |